Surgical Treatment of Hydatid Liver Disease
Cyst Extraction With Pericyst Reduction and Omentopexy as a Treatment of Choice for Hydatid Liver Disease Caused by E. Granulosus: Retrospective Observational Review of a Single Center Experience
1 other identifier
observational
72
1 country
1
Brief Summary
The goal of this observational study is to show that cyst extraction with pericyst reduction and omentopexy is a suitable treatment for liver hydatid disease caused by E.Granulossus with a low rate of complication and recurrence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 4, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedAugust 29, 2023
August 1, 2023
1 year
August 4, 2023
August 25, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Post operative complications
Listing of complications according to Clavien -Dindo classification
one month
Secondary Outcomes (1)
Recurrence rate
5 years
Eligibility Criteria
We have analyzed 72 patients diagnosed with liver hydatid disease for a period of 10 years from January 2006 until January 2017 treated surgically by cyst extraction, pericystectomy, and omentopexy.
You may qualify if:
- hydatid liver disease
You may not qualify if:
- hydatid disease present outside the liver
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Elena Zafirovikj
Skopje, 1000, North Macedonia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elena Zafirovikj, MD
UHSD St. Naum Ohridski
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
August 4, 2023
First Posted
August 14, 2023
Study Start
February 1, 2021
Primary Completion
February 1, 2022
Study Completion
March 1, 2023
Last Updated
August 29, 2023
Record last verified: 2023-08